-
1
المؤلفون: Susan Collier, Nawar Diar Bakerly, Jørgen Vestbo, John P. New, Ashley Woodcock, Jodie Crawford, Catherine Harvey, David Leather, Isabelle Boucot
المصدر: Bakerly, N D, Woodcock, A, Collier, S, Leather, D A, New, J P, Crawford, J, Harvey, C, Vestbo, J & Boucot, I 2019, ' Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups ', Respiratory Medicine, vol. 147, pp. 58-65 . https://doi.org/10.1016/j.rmed.2018.12.016Test
مصطلحات موضوعية: Male, Lydia Becker Institute, Exacerbation, Salford Lung Study, Effectiveness, law.invention, Pulmonary Disease, Chronic Obstructive, chemistry.chemical_compound, Randomized controlled trial, Adrenal Cortex Hormones, Inhaled corticosteroid, law, Medicine, Prospective Studies, Vilanterol, Lung, education.field_of_study, COPD, Incidence, Chronic obstructive pulmonary disease, Middle Aged, Disease Progression, Female, Safety, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Population, Muscarinic Antagonists, Chlorobenzenes, Fluticasone propionate, ResearchInstitutes_Networks_Beacons/lydia_becker_institute_of_immunology_and_inflammation, Internal medicine, Administration, Inhalation, Humans, education, Adverse effect, Adrenergic beta-2 Receptor Agonists, Benzyl Alcohols, Aged, Fluticasone furoate, business.industry, Pneumonia, medicine.disease, Fluticasone furoate/vilanterol, Androstadienes, chemistry, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8499e2ec66cf05b50aeb568c85c2ad9cTest
https://doi.org/10.1016/j.rmed.2018.12.016Test -
2
المؤلفون: Tim Baker, Dhvani Shah, Afisi S. Ismaila, Maurice Driessen, Ian Naya, Andrew Briggs, Nancy Risebrough
المصدر: Respiratory Medicine. 145:130-137
مصطلحات موضوعية: Male, Pulmonary and Respiratory Medicine, Quinuclidines, medicine.medical_specialty, Exacerbation, Cost effectiveness, Cost-Benefit Analysis, Muscarinic Antagonists, Umeclidinium bromide, Maintenance Chemotherapy, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Humans, 030212 general & internal medicine, Adrenergic beta-2 Receptor Agonists, health care economics and organizations, COPD, biology, business.industry, Middle Aged, Lama, biology.organism_classification, medicine.disease, Androstadienes, Treatment Outcome, 030228 respiratory system, chemistry, Delayed-Action Preparations, Ics laba, Disease Progression, Fluticasone, Drug Therapy, Combination, Female, Vilanterol, Salmeterol, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4978f1d3f949d56965475446dce97174Test
https://doi.org/10.1016/j.rmed.2018.10.024Test -
3
المؤلفون: James F. Donohue, Sally Kilbride, Clara Munzu, Dave Singh, Alison Church
المصدر: Respiratory Medicine. 112:65-74
مصطلحات موضوعية: Male, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Vital capacity, Quinuclidines, medicine.drug_class, Muscarinic Antagonists, Chlorobenzenes, law.invention, 03 medical and health sciences, FEV1/FVC ratio, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Bronchodilators, Randomized controlled trial, Double-Blind Method, law, Internal medicine, Bronchodilator, Forced Expiratory Volume, Administration, Inhalation, medicine, Humans, 030212 general & internal medicine, Benzyl Alcohols, Aged, COPD, Intention-to-treat analysis, Cross-Over Studies, business.industry, Chronic obstructive pulmonary disease, Adrenergic beta-Agonists, Middle Aged, medicine.disease, Crossover study, Bronchodilator Agents, Treatment Outcome, 030228 respiratory system, chemistry, Anesthesia, Cardiology, COPD pharmacology, Drug Therapy, Combination, Female, Vilanterol, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3059cc9ee69763d201fb311191cc5b3Test
-
4
المؤلفون: Thomas Siler, Rehan Ali, Ana R. Sousa, Alison Donald, Alison Church, Edward Kerwin
المصدر: Respiratory Medicine. 109(9):1155-1163
مصطلحات موضوعية: Male, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Vital capacity, Quinuclidines, Population, Vital Capacity, Muscarinic Antagonists, Chlorobenzenes, Fluticasone propionate, FEV1/FVC ratio, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, Double-Blind Method, Inhaled corticosteroid, Internal medicine, Forced Expiratory Volume, medicine, Clinical endpoint, Humans, education, Adrenergic beta-2 Receptor Agonists, Glucocorticoids, Benzyl Alcohols, Aged, education.field_of_study, COPD, Dose-Response Relationship, Drug, business.industry, Long-acting beta2 agonist, Middle Aged, medicine.disease, Fluticasone furoate/vilanterol, Androstadienes, Long-acting muscarinic antagonist, Drug Combinations, chemistry, Physical therapy, Quality of Life, Drug Therapy, Combination, Female, Bronchodilation, Vilanterol, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5440ddfd68b5393971b10b9554b960Test
-
5
المؤلفون: Edward Kerwin, Laurie A. Lee, Roopa Trivedi, Steven Pascoe, Shuying Yang, Lisa D. Edwards
المصدر: Respiratory Medicine. 109:54-62
مصطلحات موضوعية: Adult, Male, Pulmonary and Respiratory Medicine, Vital capacity, Adolescent, Trough FEV1, Fixed-dose combination, Muscarinic antagonist, Muscarinic Antagonists, Umeclidinium bromide, Fluticasone propionate, Young Adult, chemistry.chemical_compound, Double-Blind Method, Inhaled corticosteroid, Forced Expiratory Volume, Administration, Inhalation, Humans, Medicine, Glucocorticoids, Asthma, Cross-Over Studies, Dose-Response Relationship, Drug, business.industry, Middle Aged, medicine.disease, Dose-ranging study, Crossover study, Bronchodilator Agents, Androstadienes, Drug Combinations, Treatment Outcome, chemistry, Anesthesia, Female, Vilanterol, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7913a7ef1664f6e9869b7761b850545Test
https://doi.org/10.1016/j.rmed.2014.09.012Test